Sovremennaya terapiya khronicheskogo zapora
- Authors: Parfenov A.I.1
-
Affiliations:
- Issue: No 11 (2012)
- Pages: 31-36
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/279663
- ID: 279663
Cite item
Abstract
Constipation is a frequent clinical syndrome, which occurs in approximately 20 % of the population. In recent decade, studies have contributed to a better understanding of the basic mechanisms of chronic constipation (CC), in particular its relationship to colonic transit and anorectal function. Many possible causes that affect the occurrence of constipation (metabolic, deficiency of fiber, medicines) should be taken into account during examination of the patient, and anorectal pathology should be excluded. Functional CC consists of three subtypes: slow-transit constipation, dyssynergic defecation and irritable bowel syndrome with predominance of constipation. Rome criteria are a useful guideline for the diagnosis of functional constipation. Treatment should be based on evidence-based diagnosis of CC variants. Enterokinetic agents such as prucalopride and lubiprostone should be used in the treatment of an inert colon. Advantages of biofeedbacktherapy should be used in the treatment of dyssynergic defecation.
Full Text
![Restricted Access](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
References
- Лазебник Л.Б., Прилепская С. И., Парфенов А. И. и др. Распространенность и факторы риска запоров у взрослого населения Москвы по данным популяционного исследования “МУЗА"// Эксперим. и клин. гастроэнтерология 2011. № 3. С. 68-73.
- Парфенов А.И. Энтерология: руководство для врачей. 2-е изд. М., 2009. 800 с.
- Camilleri M, Deiteren A. Prucalopride for constipation. Expert Opin Pharmacother 2010;11:451-61.
- Cash BD, Chey WD. Review article: the role of serotonergic agents in the treatment of patients with primary chronic constipation. Aliment Pharmacol Ther 2005;22:1047-60.
- Drossman DA. The Functional Gastrointestinal Disorders and the Rome III Process. 8. Gastroenterology 2006;130(5):1377-90.
- Johanson JF, Wald A, Tougas G, et al. Effect of tegaserod in chronic constipation:a randomized, double-blind, controlled trial. Clin Gastroenterol Hepatol 2004;2:796-805.
- Lacy BE, Levy LC. Lubiprostone: a novel treatment for chronic constipation. Clin Interv Aging 2008;3:357-64. Rao SSC. Dyssynergic Defecation. Gastroenterol Clin North Am 2001;30:97-114.
Supplementary files
![](/img/style/loading.gif)